問卷

TPIDB > Principal Investigator

Principal Investigator


E-DA Hospital (在職)

Division of Thoracic Medicine

National Yang-Ming University Hospital (在職)

Division of General Internal Medicine

Division of Cardiovascular Diseases

國立陽明交通大學附設醫院

Division of Cardiovascular Diseases

更新時間:2023-09-19

陳思穎
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

3Cases

2026-06-01 - 2030-06-30

Phase III

Not yet recruiting
A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Study to Evaluate the Effect of Elecoglipron in Reducing Cardiovascular Outcomes in Participants with HFpEF and HFmrEF (Elevate-HF)
  • Condition/Disease

    Sacroiliac Joint Pain

  • Test Drug

    Dapagliflozin Elecoglipron

Participate Sites
14Sites

Recruiting14Sites

2025-07-01 - 2030-12-31

Active
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
23Sites

Recruiting23Sites

2020-06-15 - 2026-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
12Sites

Not yet recruiting4Sites

Recruiting8Sites